BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Moodys
Fish and Richardson
Express Scripts
Baxter
AstraZeneca
Cerilliant
Dow
Chinese Patent Office

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074461

« Back to Dashboard

NDA 074461 describes INDAPAMIDE, which is a drug marketed by Actavis Elizabeth, Amerigen Pharms Ltd, Ani Pharms Inc, Mylan, Mylan Pharms Inc, Sandoz, Teva, and Watson Labs, and is included in nine NDAs. It is available from eleven suppliers. Additional details are available on the INDAPAMIDE profile page.

The generic ingredient in INDAPAMIDE is indapamide. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the indapamide profile page.
Summary for 074461
Tradename:INDAPAMIDE
Applicant:Mylan
Ingredient:indapamide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074461
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for 074461
Suppliers and Packaging for NDA: 074461
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDAPAMIDE indapamide TABLET;ORAL 074461 ANDA Mylan Pharmaceuticals Inc. 0378-0069 0378-0069-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0069-05)
INDAPAMIDE indapamide TABLET;ORAL 074461 ANDA Mylan Pharmaceuticals Inc. 0378-0069 0378-0069-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0069-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Mar 27, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.25MG
Approval Date:Mar 26, 1997TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
McKesson
Boehringer Ingelheim
Farmers Insurance
Merck
Citi
AstraZeneca
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot